Top Markets
#1 Black Phoenix Black Phoenix +346.11%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +67.06%
#4 Gold Park Gold Park +58.03%
#5 Acurast Acurast +36.59%
#6 OpenEden OpenEden +32.83%
#7 BasedHype BasedHype +27.23%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.76%
#9 Cryptopia Cryptopia +21.54%
#10 Avantis Avantis +16.89%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Endo International plc Endo International plc

Endo International plc

0Y5F
Classement en actions #40683
Endo International plc is a specialty pharmaceutical company that develops,... Endo International plc is a specialty pharmaceutical company that develops, manufactures, and markets both branded and generic medications across the United States and globally. Its operations are divided into several key segments: Branded Pharmaceuticals: This division offers a portfolio of signature prescription medications, addressing conditions such as Dupuytren's contracture (XIAFLEX), central precocious puberty (SUPPRELIN LA), vitamin B12 deficiency (NASCOBAL), hypogonadism (AVEED), and moderate-to-severe cellulite (QWO). It also includes treatments for moderate to moderately severe pain (PERCOCET), testosterone replacement therapy (TESTOPEL), erectile dysfunction (EDEX), and pain relief with topical patches (LIDODERM), among other pain management and urology products. Sterile Injectables: This segment is responsible for producing essential branded formulations like VASOSTRICT (a vasopressin injection) and ADRENALIN (an adrenergic agonist), as well as APLISOL, a sterile aqueous solution. It also develops and supplies various generic sterile injectable products, including ertapenem and ephedrine sulfate injections. Generic Pharmaceuticals: This segment encompasses a wide array of generic drug formulations, spanning various delivery methods including solid oral extended and immediate-release forms, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. International Pharmaceuticals: Operating globally, this segment provides specialized pharmaceutical products across diverse therapeutic categories such as attention deficit hyperactivity disorder (ADHD), pain management, women's health, oncology, and transplantation. Endo distributes its branded and generic products through a broad network of channels, reaching specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialized distributors. The company was established in 1920 and maintains its headquarters in Dublin, Ireland. A significant recent development occurred on August 16, 2022, when Endo International plc, along with its affiliated entities, initiated bankruptcy proceedings by filing a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
Prix de l'action
$0.0006
Dernière synchronisation: 2024-04-24
Capitalisation boursière
$98.97K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
IE
Échange Endo International plc (0Y5F)

Catégorie

Healthcare
Ratio P/E pour Endo International plc (0Y5F)
Ratio P/E au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Endo International plc, le ratio P/E actuel (TTM) est de 0. À la fin de l’année 2026, le P/E de l’entreprise était de 0.
Historique du ratio P/E pour Endo International plc de 2026 à 2026
Ratio P/E à la fin de chaque année
Année Ratio P/E Changez
Pas assez de données pour les dates fournies.
Ratio P/E pour des entreprises similaires ou concurrentes
Entreprise P/E Ratio Différence du P/E Ratio Pays
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 23.71 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 220.17 -
US
Comment lire un P/E ratio ?

Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.

Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.

Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.